Group 1 - The "Baoqi Jinfeng" investment and financing conference in Bao'an District attracted 426 companies and 132 financial institutions, creating a positive interaction between enterprises and capital [1] - The conference provided a platform for companies to directly connect with investors, reducing the need for intermediaries, which is particularly beneficial for small and medium-sized enterprises [3] - The event featured various sub-forums and listing guidance services, addressing the financing needs of small and medium-sized enterprises [3] Group 2 - Pure Jun New Materials, a company focused on liquid cooling servers, plans to use funds from upcoming financing rounds for product research and expansion, aiming for domestic substitution in the industry [4] - Shenzhen Tengjinda Information Technology expressed the need for banks to promote research and development loans, particularly for intangible assets like intellectual property [5] - Cloud Venture Capital, which has been in Bao'an for ten years, reported a high refinancing rate of over 80% among incubated companies, highlighting the strong manufacturing base and efficient business environment in Bao'an [6] - Shenzhen Rongxin Medical Technology secured a 100 million yuan research and development loan from China Bank, emphasizing the high efficiency of financing processes in Bao'an [6]

以下文章来源于智通财经APP ，作者智通编选 智通财经APP . 智通财经APP，连线全球资本市场。内容合作/内容举报请联系李先生： Tel: +86-15121009144 Email:zhitongcolumn@163.com 来源 | 智通财经APP 想布局长期投资却找不到方向？瑞银最新报告给出了答案。2025 年 9 月，瑞银首席投资办公室（CIO）发布月度报告，聚焦长期投资 （LongTerm Investment）主题的估值、动量与质量指标，结合定量模型与分析师定性判断，筛选出当前最具吸引力的入场点主题，同时提示了 短期需谨慎的领域。这份报告不仅明确了 "该投什么"，更解释了 "为什么现在投"，对普通投资者有参考价值。 值得注意的是，"发掘下一个前沿市场" 是首次进入 Top 5，而 "金融科技" 从之前的第 5 名稳步提升；短期视角下，瑞银建议投资者可减少对 "基因疗法" 和 "医疗科技" 的敞口，优先考虑上述 5 大主题。 | | | | Quantitative assessment | | Qualitative assessment | | | --- | --- | --- | --- ...

该贷款将为硼中子俘获治疗中心的建设提供更多助力，争取该中心在2025年年底开幕及开始营运，为有 需要癌症患者提供硼中子治疗服务。凭借博鰲乐城先行区的支持政策及以该中心作为示范，集团未来致 力发展建构覆盖中国的硼中子俘获治疗中心网络，发展特许经营医院，以创造更多的收入。 智通财经APP讯，中国生物科技服务(08037)发布公告，于2025年9月9日，鹏博(海南)硼中子医疗科技有 限公司(鹏博(海南)，于中国成立的有限公司，并于本公告日期为公司的间接全资附属公司，作为借款 人)与海南农村商业银行股份有限公司琼海支行(作为贷款人)订立一份贷款合同。据此，贷款人同意向鹏 博(海南)提供本金最高为人民币1.8亿元的贷款。 ...

CHINA BIOTECH SERVICES HOLDINGS LIMITED 中國生物科技服務控股有限公司 （於開曼群島註冊成立並在百慕達繼續營業之有限公司） （股份代號：8037） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 保證 ： (1) 抵押鵬博（海南）名下位於博鰲樂城先行區的土地使用權、 地上在建工程，以及硼中子治療的醫療設備； 反擔保 ： 鑑於第三方擔保人為該貸款提供保證擔保，本公司將向第三 方擔保人提供連帶責任保證，且鵬博（海南）的直接控股公司 將質押鵬博（海南）的100%股權予第三方擔保人，作為反擔保。 自願公告 銀行向本公司附屬公司授出貸款 本公告乃由中國生物科技服務控股有限公司（「本公司」，連同其附屬公司，統稱 為「本集團」）作出之自願公告。 本公司之董事（「董事」）會（「董事會」）欣然宣佈，於二零二五年九月九日，鵬博（海 南）硼中子醫療科技有限公司（「鵬博（海南）」）（於中華人民共和國（「中國」）成立 之有限公司，並於本公告 ...

Core Viewpoint - The development of a new fluorescent molecular palette named "Lanthanide Rainbow" by a research team from Fudan University enhances surgical precision and safety by enabling high-resolution imaging of complex organ structures during operations [1][2]. Group 1: Technology and Innovation - The "Lanthanide Rainbow" molecular palette overcomes light-tissue interaction challenges, achieving high-resolution nine-color imaging in deep tissues [1]. - The research team utilized the unique optical properties of the rare earth element erbium and introduced an innovative "excitation coding, single emission" strategy to improve photon utilization efficiency and image fidelity across different wavelengths [2]. - The new method ensures consistent high contrast across all imaging channels, allowing for precise differentiation of nine high-fidelity signals even in deep tissues [2]. Group 2: Application and Impact - The AI-assisted "Lanthanide Rainbow" molecular palette successfully guided surgeries in a colorectal cancer mouse model using five-color fluorescence [2]. - The system can simultaneously visualize tumor primary sites, metastatic nodules, blood vessels, and intestinal movements, providing real-time anatomical and functional information during surgery [2]. - Future applications may enable surgeons to view dynamic images of tumors, blood vessels, lymph nodes, and intestines in real-time, significantly enhancing the ability for precise excision and intraoperative decision-making [2].

Core Conclusion - UBS identifies five key long-term investment themes as the best entry points: Digital Consumers, Diversity and Equality, Enabling Technologies, Fintech, and Identifying the Next Frontier [1][2] Investment Themes 1. Digital Consumers - Investment Logic: The younger generation, particularly Gen Z, is reshaping consumption patterns, prioritizing shared experiences over ownership. AI plays a crucial role in transforming traditional sectors like travel and entertainment, alongside emerging areas such as the metaverse and social media [2] - Current Investment Rationale: Ranked first this month due to strong quality metrics, with companies showing robust balance sheets and high returns on invested capital. However, valuations are relatively high due to a focus on growth sectors [2] 2. Diversity and Equality - Investment Logic: Global regulations are increasingly pushing companies to disclose diversity data and reduce disparities. Enhanced diversity is expected to narrow the wealth gap and potentially drive GDP growth over the next decade [3] - Current Investment Rationale: Valuations are reasonable, and quality scores are high. This theme is cross-industry, offering defensive, value, and growth attributes, with strong risk resilience [3] 3. Enabling Technologies - Investment Logic: Generative AI is accelerating technological convergence, with UBS focusing on five categories: AI, AR/VR, big data, 5G, and breakthrough technologies. These technologies are expected to reshape multiple industries, with a high proportion of hardware and software, particularly semiconductors [4] - Current Investment Rationale: Strong momentum and attractive valuations, with a focus on the IT sector, which is currently performing well. The AI market is projected to reach $2.6 trillion by 2030, with a compound annual growth rate (CAGR) of 41% from 2024 [5] 4. Fintech - Investment Logic: Urbanization, demand from younger demographics, and policy support are driving the fintech sector, with revenues expected to grow from $310 billion in 2024 to $580 billion by 2030. Key areas include leading payment companies and emerging technologies like distributed ledgers and AI [6] - Current Investment Rationale: Continuous improvement in momentum aligns with UBS's positive outlook on the U.S. financial sector. After a period of valuation decline, fintech companies are shifting focus from scale to profitability, supported by advancements in AI and a favorable regulatory environment [6] 5. Identifying the Next Frontier - Investment Logic: Emerging and frontier economies are projected to be the main drivers of global GDP growth over the next decade, with over 50% of the population in the top 10 developing economies by 2024. These markets can convert economic growth into corporate profitability [7] - Current Investment Rationale: The appeal of emerging markets is increasing due to the expanding U.S. fiscal deficit and a weakening dollar. Investors are likely to favor these markets for diversification, especially with potential interest rate declines in the second half of the year [7] Short-term Cautions - Gene Therapy & Medical Technology: Currently ranked low in quantitative models, lacking short-term catalysts. The biotech sector faces significant capital constraints, and medical technology companies need to demonstrate profitability and scalability [8] - Smart Mobility: Due to improved valuations and momentum, this theme has been removed from the caution list, with positive developments expected from upcoming industry events [9]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688246 证券简称：嘉和美康 公告编号：2025-062 嘉和美康（北京）科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 股东持有的基本情况 截至本公告披露日，嘉和美康（北京）科技股份有限公司（以下简称"嘉和美康"或"公司"）股东苏州赛 富璞鑫医疗健康产业投资中心（有限合伙）（以下简称"赛富璞鑫"）持有公司股份2,672,492股，占公司 股份总数的1.94%。上述股份为嘉和美康首次公开发行并上市前取得的股份，且已于2022年12月14日起 上市流通。 股东过去12个月内减持股份情况 ■ 二、减持计划的主要内容 ■ 预披露期间，若公司股票发生停牌情形的，实际开始减持的时间根据停牌时间相应顺延 ● 减持计划的主要内容 公司于2025年9月10日收到赛富璞鑫出具的《关于股东减持计划的告知函》，因股东流动性需求，股东 赛富璞鑫计划根据市场情况拟通过集中竞价方式减持其持有的公司股份不超过2,672, ...

9月10日至14日2025年服贸会期间，健康卫生服务专题在北京首钢园区举办。本届专题以"智领未来，健 康生活"为主题，设置专题展并同期举办"首都国际医学（000516）大会"等近20场各类会议、论坛和配 套活动。世界500强及行业龙头企业参展率达到54%，国际化率达53%。 ...

转自：龙头新闻·黑龙江日报 黑龙江展馆 北大荒展台前围满了观众，袋装长粒香米颗粒饱满、泛着油亮光泽，桶装非转基因豆油澄澈透明，精致 包装的杂粮礼盒码得整整齐齐。"这米产自松嫩平原黑土带，煮出来的饭自带清甜！"北大荒食品有限公 司福州分公司福州区经理林运彩介绍，"黑龙江的黑土是'耕地中的大熊猫'，从种植到加工我们全程严 把控，就是要把最纯的龙江味送到南方餐桌。"据他透露，企业已经参加了多届投洽会，以往投洽会帮 产品敲开了福建商超、社区便利店的大门，这次还要进一步拓展市场。 9月8日，第二十五届中国国际投资贸易洽谈会在厦门开幕。黑龙江展区凭借"冰雪、科技、农业、中俄 合作"四大核心主题，以鲜活展品与互动场景成为全场焦点，全方位展现出龙江的地域特色与产业活 力。 舌尖上的龙江：黑土珍品圈粉无数 农业展区是黑龙江馆的"人气担当"，从黑土地里长出来的米面粮油，到山林间藏着的珍稀特产，满 满"龙江风情"让参观者挪不开眼，咨询声、赞叹声不绝。 另一侧的大兴安岭富林山野珍品展位同样热闹，有机木耳舒展厚实，野生榛蘑、元蘑裹着自然菌香，瓶 装桦树汁清透亮泽，不少年轻参观者举着手机拍照打卡。"我们带来了有机山珍、野生浆果制品等3大 ...

Core Viewpoint - The company has made significant advancements in the artificial intelligence sector by developing a self-evolving multimodal intelligent architecture, which has led to the creation of a revolutionary intelligent health examination report system that is currently being trialed by partner institutions [1] Group 1: Technological Advancements - The new system utilizes a top-tier expert thinking chain model that continuously learns and updates medical frontier knowledge [1] - It comprehensively analyzes user health examination images, tests, and medical history data to generate personalized health reports [1] - The system significantly reduces misdiagnosis and missed diagnosis rates by eliminating human biases and accurately identifying complex health risks [1] Group 2: Industry Impact - The transition from traditional health examinations to intelligent examinations represents not only a technological improvement but also an industrial transformation [1] - The system enables real-time collaboration with remote medical nodes, generating expert-level reports in seconds [1] - It ensures that primary healthcare institutions have access to the analytical capabilities of top-tier hospitals, allowing high-quality medical resources to be accessible without boundaries [1]